StockNews.AI
LFMD
StockNews.AI
7 hrs

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD

1. LifeMD is under investigation for significant stock losses. 2. Stock revenue guidance lowered from $268-275M to $250-255M. 3. LifeMD shares fell 44.8% following Q2 2025 results announcement. 4. Faruqi & Faruqi law firm is probing potential claims against LifeMD.

9m saved
Insight
Article

FAQ

Why Very Bearish?

The significant revenue guidance cut coupled with a 44.8% drop indicates severe investor loss and mistrust in LifeMD's future performance.

How important is it?

Legal investigations can lead to increased volatility, impacting investor sentiment and stock price significantly.

Why Short Term?

Ongoing investigation and past financial performance may continue to hinder stock performance in the near future.

Related Companies

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In LifeMD To Contact Him Directly To Discuss Their Options

If you suffered significant losses in LifeMD stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ:LFMD).

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

On August 5, 2025, after the market closed, LifeMD reported its financial results for the second quarter of 2025. In this announcement, LifeMD announced revised guidance. Among other metrics, LifeMD stated that it was expecting total revenue in the range of $250 to $255 million, compared with previous guidance of $268 to $275 million.

On this news, LifeMD's stock plummeted 44.8% on August 6, 2025.

To learn more about the LifeMD investigation, go to www.faruqilaw.com/LFMD or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

Faruqi & Faruqi, LLP

Josh Wilson

877-247-4292 or 212-983-9330 (Ext. 1310)

Related News